Cancer News and Research

Latest Cancer News and Research

Development of VLN cigarettes for use in smoking cessation continues: 22nd Century

22nd Century Limited, LLC is pleased to announce that it is continuing development of a very low nicotine cigarette for use in smoking cessation. Clinical trial results demonstrate that these cigarettes, also referred to as ‘nicotine-free’ and ‘denicotinized,’ may be more effective for quitting than FDA-approved therapies.

28 Oct 2009

IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENI

Affymetrix, Inc. announced today that the Institute for Pharmacogenomics and Individualized Therapy (IPIT) at the University of North Carolina in Chapel Hill is using the company’s DMET™ Plus biomarker panel to expand the Pharmacogenetics for Every Nation Initiative (PGENI).

28 Oct 2009

RadMD offers tips for efficient use of medical imaging during clinical trial process

Lengthier cancer trials and new regulations have forced pharmaceutical companies to look for new ways to minimize costs and increase efficiency. As a result, the use of medical imaging, which is currently being used in 3000 clinical trials, has come to the forefront.

28 Oct 2009

New biotechnology research center launched by SHRO

The Sbarro Health Research Organization (SHRO), a nonprofit research facility located at Temple University, will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m. SHRO is one of the top three international laboratories, based on number of publications as ranked by the Cell Cycle Registry,

28 Oct 2009

NPC, PMC to explore comparative effectiveness research for effective health care treatments

As Congress continues its efforts to reform the health care system, the National Pharmaceutical Council (NPC) and the Personalized Medicine Coalition (PMC) will host a conference tomorrow to explore a key topic in the debate: using comparative effectiveness research (CER) to determine which health care treatments are most effective while improving the quality of patient care through personalized medicine.

28 Oct 2009

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.

28 Oct 2009

BC Children's Hospital Foundation names Eagle Point townhome as a "Super Community"

The Eagle Point townhome complex in Port Moody was named a Super Community by BC Children's Hospital Foundation. The Search for a Super Community program was launched on September 21 on Global BC TV.

28 Oct 2009

Health assessment may have some influence on health behaviors, say researchers

With open enrollment now underway at many companies, employees will be making decisions about their health care coverage for 2010. As part of their health plan enrollment, they may be asked to complete a health questionnaire known as a health assessment.

28 Oct 2009

Data from Phase II clinical trial of NKTR-118 presented

Data from a phase II study demonstrated that oral NKTR-118 improved lower gastrointestinal dysfunction by increasing the frequency of bowel movements in patients with opioid-induced constipation, while simultaneously preserving opioid-mediated analgesia.

28 Oct 2009

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Officials at Endocyte Inc., a cancer drug discovery and development company, announced Tuesday (Oct. 27, 2009) that the company has been awarded a patent from the U.S. Patent and Trademark Office covering vitamin receptor binding anti-cancer agents.

28 Oct 2009

Ohio State University researchers first to observe real-time behavior of the Dpo4 enzyme

Scientists here have identified how the motions of an enzyme are related to correctly copying genetic instructions, setting the stage for studies that can uncover what happens when DNA copying mistakes are made.

28 Oct 2009

First nationwide Prostate Cancer registry for identifying effective treatment options

RemedyMD (www.RemedyMD.com), the leading provider of Patient registry software, today announced the first nationwide Prostate Cancer registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

28 Oct 2009

Bcl-2 inhibitor may enhance chemotherapy treatment in patients with prostate cancer

In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.

28 Oct 2009

20% of Accuray in U.S. to utilize Accuray's Treatment Planning Service

Accuray Incorporated, a global leader in the field of radiosurgery, announced today that 20 percent of the company's U.S. installed base has signed on to utilize Accuray's Treatment Planning Service. This demonstrates a significant increase over the 10 percent of U.S. sites that had signed on as of February 2009.

28 Oct 2009

MMRF raises over $1.8 million at its 13th annual Fall Gala

The Multiple Myeloma Research Foundation (MMRF) raised over $1.8 million at its 13th annual Fall Gala held on Saturday evening in Greenwich, Conn. Funds raised at this premier fundraising event, attended by more than 1,000 guests, will support the MMRF’s efforts to accelerate the development of the next generation of treatments for patients with multiple myeloma, a rare and incurable blood cancer, and to find a cure for the disease.

28 Oct 2009

Recruitment of Phase II trial of TB-402 completed ahead of schedule

ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule.

28 Oct 2009

Manhattan Scientifics and Senior Scientific team up to commercialize cancer detection technology

Manhattan Scientifics (OTCBB: MHTX) and Senior Scientific, LLC announced today that they have begun cooperative work to commercialize Senior Scientific’s nano medicine cancer detection technology.

28 Oct 2009

Multidisciplinary center to be launched for treatment of advanced liver disease

Distinguished transplant and cancer surgeon, Alan Hemming, MD, has been recruited to the University of California, School of Medicine to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical Center and Moores UCSD Cancer Center.

28 Oct 2009

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

Ghosts and goblins aren't the only spooky things lurking around this Halloween. A new report by the Campaign for Safe Cosmetics reveals that popular children's face paints contain lead, a potent neurotoxin, as well as nickel, cobalt and chromium, which can cause lifelong skin sensitization and contact dermatitis.

28 Oct 2009

Barrett's esophagus patients are at no greater risk of dying from esophageal cancer

New Mayo Clinic research has found that survival rates of patients with Barrett's esophagus, which can be a precursor for esophageal cancer, are no different than the survival rates for the general population. These findings were presented today at the 2009 American College of Gastroenterology (ACG) Annual Meeting in San Diego.

28 Oct 2009

Cancer News and Research

Latest Cancer News and Research

Development of VLN cigarettes for use in smoking cessation continues: 22nd Century

IPIT uses Affymetrix’s DMET Plus biomarker panel to expand the PGENI

RadMD offers tips for efficient use of medical imaging during clinical trial process

New biotechnology research center launched by SHRO

NPC, PMC to explore comparative effectiveness research for effective health care treatments

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

BC Children's Hospital Foundation names Eagle Point townhome as a "Super Community"

Health assessment may have some influence on health behaviors, say researchers

Data from Phase II clinical trial of NKTR-118 presented

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Ohio State University researchers first to observe real-time behavior of the Dpo4 enzyme

First nationwide Prostate Cancer registry for identifying effective treatment options

Bcl-2 inhibitor may enhance chemotherapy treatment in patients with prostate cancer

20% of Accuray in U.S. to utilize Accuray's Treatment Planning Service

MMRF raises over $1.8 million at its 13th annual Fall Gala

Recruitment of Phase II trial of TB-402 completed ahead of schedule

Manhattan Scientifics and Senior Scientific team up to commercialize cancer detection technology

Multidisciplinary center to be launched for treatment of advanced liver disease

Toxic chemicals in face paints can cause skin sensitization and contact dermatitis

Barrett's esophagus patients are at no greater risk of dying from esophageal cancer

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in